on Monday announced the appointment of Norman Staskey as its Chief Financial Officer (CFO). Staskey joins from Danforth Advisors, where he has served since 2021, providing CFO services to clients ...
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...
Organovo Holdings, Inc., a clinical stage biotechnology company focused on treating inflammatory bowel disease (IBD), has appointed Norman Staskey as the new Chief Financial Officer. Staskey ...
today announced that it had appointed Norman Staskey as Chief Financial Officer. Mr. Staskey has worked for Danforth Advisors since 2021, working as Chief Financial Officer for clients such as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback